Health goals: impact of intervention delivered through professional soccer clubs

• Univadis Medical News
• 15 February 2019

The programme was delivered through 15 professional football clubs including Arsenal, Manchester City, FC Groningen, Vålerenga and SL Benfica.

How long will a knee replacement last?

• Univadis Medical News
• 15 February 2019

Generalisable survival data is available for the first time to estimate how long hip and knee replacements are likely to last.

Neurodevelopmental impact of general anaesthesia in infancy

• Univadis Medical News
• 15 February 2019

Findings from the first trial of its kind, involving 722 infants.

Suicidal ideation in 3-6 yr olds must be taken seriously, study finds

• Univadis Medical News
• 15 February 2019

Findings refute common assumptions that depressed children who express suicidal ideation have a 'less mature' understanding of death.

ADHD: dasotraline safe and effective in children 6-12 yrs

• Univadis Medical News
• 14 February 2019

Dasotraline, a potent inhibitor of presynaptic dopamine and norepinephrine reuptake, shown to be effective and safe.

ASCO-GI 2019—Durvalumab-tremelimumab extends OS in refractory CRC

• Univadis
• 23 January 2019

Immune checkpoint blockade shows activity in patients with rCRC with no known dMMR tumors.

ASCO-GI 2019—FTD/TPI effective for mGC regardless of prior gastrectomy

• Univadis
• 23 January 2019

TAGS phase 3 study of patients with heavily pretreated metastatic gastric cancer.

ASCO-GI 2019—NACT tops upfront surgery for PDAC in phase 2/3 trial

• Univadis
• 23 January 2019

Gemcitabine plus S-1 extends OS in Japanese randomized study.